Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management

Detalles Bibliográficos
Autores principales: Heskin, Joseph, Pallett, Scott J C, Mughal, Nabeela, Davies, Gary W, Moore, Luke S P, Rayment, Michael, Jones, Rachael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718360/
https://www.ncbi.nlm.nih.gov/pubmed/34973713
http://dx.doi.org/10.1016/S0140-6736(21)02657-X

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718360/
https://www.ncbi.nlm.nih.gov/pubmed/34973713
http://dx.doi.org/10.1016/S0140-6736(21)02657-X

Ejemplares similares